
Baofa Yu, M.D. Chief Physician ku China, Adjunct Professor ku University of Texas (El Paso) (2016) ndi Adjunct Professor ku Western University of Health Sciences (2016). Anamaliza maphunziro ake ku Peking Union Medical College (Peking Union Medical College) ku 1988. Iye anali mnzake wapambuyo pa udokotala ku UCSD kuchokera ku 1990 mpaka 1991, Salk kuchokera ku 1992 mpaka 1993, Pulofesa Wothandizira, UCSD kuchokera ku 1994 mpaka 1998. Adapanga lingaliro latsopano logwiritsa ntchito minofu ya chotupa ngati njira yotulutsira mankhwala oletsa khansa komanso njira yochizira yosungira yotulutsa, yomwe imakhala ndi phindu lachipatala, imatchedwanso ultro-Minimum incision personalized intratumoral chemoimmunotherapy (UMIPIC). Mu 1998, anabwerera ku China ndipo anayambitsa Shandong Baofa Research Institute ndi Taimei Baofa Cancer Hospital ku Dongping m'dera la kumidzi ndi ndalama zamakono, ndipo anatumikira monga wapampando wa Shandong Baofa Cancer Treatment Co., LTD., Kenako anakhazikitsa Jinan Baofa Cancer Hospital (2004). Dongping Baofa General Hospital (2011), Beijing Baofa Cancer Hospital (2013) ndi Immuno Oncology Systems, Inc. UMIPIC iyi ndi yotetezeka, yosavuta kugwiritsa ntchito, komanso yoberekana ndi phindu labwino kwa chotupa chonse cholimba. Masiku ano mankhwalawa amavomerezedwa ku "Clinical Operation Guidelines for Interventional Treatment of Advanced Pancreatic Cancer" (mayesero) (7th edition), yopangidwa ndi Chinese Anti-Cancer Association, National Clinical Medical Research Center for Radiology and Therapy, ndi National Interventional Medicine Innovation Alliance, Journal of Clinical Radiology, voliyumu 94, 6162018.
Iye wasindikiza mapepala oposa 60 okhudza mankhwalawa mu Chilengedwe: Lipoti la Sayansi, Journal of Cancer, J Basic Clin Pharma, J Immunological Sci, Japanese Journal of Gastroenterology and Hepatology, Novel Approaches in Cancer Study, Academic Journal of Engineering Studies, Nov Res Sci, Journal of Hepatocellular carcinoma, Matenda a khansa ya m'mapapo, Target Journal of Cancer, Living Journal of Lung of Chest,Proc.Natl.Acad.Sci.USA, Pancreas ndi magazini ena ndi mapepala ambiri adatenga nawo gawo pa msonkhano wa AACR ndi ASCO.
Chothandizira chathu chachikulu ndikuti chithandizo chamankhwala chokhazikika chimagwirizanitsa ubwino wa chemotherapy ndi immunotherapy, ndipo kwa nthawi yoyamba, awiriwa aphatikizidwa ndikugwiritsidwa ntchito ku intratumoral therapy kupyolera mwa kuchitapo kanthu. Imaphatikiza chithandizo chapadziko lonse lapansi komanso chapadziko lonse lapansi, ndikuwonjezera kuchuluka kwamankhwala ndi nthawi yamankhwala kudzera pakutulutsa kwanthawi zonse kwamankhwala mkati mwa chotupacho, chomwe sichimangogwira ntchito yoletsa khansa ya m'dera la chemotherapy, komanso imaganiziranso ntchito ya systemic immunotherapy, potero imapanga zofooka za njira zina zochiritsira, kupereka malingaliro ndi njira zatsopano zochizira khansa, makamaka zotupa zapakati komanso zapamwamba, makamaka pochepetsa kufunikira kwa chotupa; Chithandizo cha UMPIC chili ndi mwayi wogwiritsa ntchito chotupa ngati gwero la antigen komanso katemera wa autologous, zomwe zimagwirizananso ndi kakulidwe ka Personalized Medicine. Ndipo amagwiritsidwa ntchito ku chipatala, hapten pamodzi ndi mankhwala a chemotherapy kuti apitirize kumasulidwa kwa khansa ya pancreatic, pamene imayambitsa zotsatira za distal, zomwe zimachititsa kuti chitetezo cha mthupi chitetezeke, T-cell zokhudzana ndi CD4, CD8, DC, T ndi NK maselo, ndi B-maselo okhudzana ndi chotupa autoantibodies: Antibodies to P53, P16, Cmy2c, Survey, HCC ndi ma oncogenes ena, aka ndi nthawi yoyamba kupeza kuti T ndi B akukhudzidwa ndi kuyankha kwa chitetezo cha mthupi, ndi ntchito zachipatala za zotsatira za distal ndi chithandizo ichi chinasankhidwa kuti "Clinical Operation Guidelines for Interventional Treatment of Advanced Pancreatic Cancer" (Mayesero) (7th edition) yopangidwa ndi Chinese Anti-Cancer Association, National Clinical Medical Research Center ndi National Clinical Research Center yofalitsidwa ndi National Clinical Medical Research and Interrapy Alliance yofalitsidwa. pa Journal of Clinical Radiology, voliyumu 43, nambala 19, 2024, 1636-1648.
| Chaka | Mutu wa Nkhani | Zofalitsa |
| 2015 | Thandizo lowonjezera la Hapten mu magawo apamwamba a khansa ya m'mapapo ndi ultra-minimum incision personalized intratumoral | Khansara ya m'mapapo: Target ndi Therapy, 2015; 6 1-11 |
| 2015 | Kuteteza yachibadwa kuti bwino kupha khansa | 2015 Olemba. Cancer Medicine lofalitsidwa ndi John Wiley & Sons Ltd.1349-1403 |
| 2015 | Zofooka ndi Mavuto Ogwiritsa Ntchito Mbewa ndi Makoswe mu Cancer Chemoprevention Studies | Journal of Cancer 2015;6(10): 1058-1065.doi: 10.7150/jca.12519 |
| 2015 | Nthawi yowonjezera ya Hapten yopulumuka mu advanced hepatocellular carcinoma ndi ultra-minimum incision personalized intratumoral chemoimmunotherapy. | Journal of Hepatocellular Carcinoma, 2015:2,1-12 |
| 2015 | Kugwiritsa Ntchito Hapten Combinded Catatonic Drug for Enhancing Therapeutic Effect in Advanced Stages of Pancreatic Cancer | Journal of Chiwindi Research, Disorders & Therapy, 2015,1(3):013-23 |
| 2016 | Kuphunzira za Kufunika Kopewera Kusintha kwa Kusintha kwa Makhansa Ochiritsira ndi Zotupa Zowopsa | Journal ya Cancer 2016; 7(4): 436-445. doi: 10.7150/jca.13832 |
| 2016 | Ubwino Wopulumuka wa Hapten Pamapeto a Khansa Yam'mapapo Yopanda Yang'ono (NSCLC) yolembedwa ndi Ultra-Minimum Incision Personalized Intratumoral Chemo Immunotherapy (UMIPIC) Therapy yokhala ndi popanda radiation Therapy Tumizani Zolemba | Journal of Cancer Prevention & Current Research 2016, 4 (2): 00116 |
| 2020 | Njira ya Novel Eclectic for Cancer Therapy yokhala ndi Liquid Knife & Immuno Therapy: UMIPIC, itha Kupitilira Opaleshoni Yambiri, Chemotherapy ndi Radiation Therapy pamagawo onse a Chotupa Cholimba. | Njira Zatsopano mu Phunziro la Cancer NACS.000590. 4 (3) 2020 |
| 2020 | Mankhwala Osakanikirana ndi H2O2 Injection Intratumoral kuti asandutse Extracellular Matrix kukhala Autologous Coagulum monga Drug Depot | Kafukufuku Watsopano mu Sayansi NRS.000584. 4 (2) 2020 |
| 2020 | Chiyembekezo Chatsopano cha Cancer Therapy ndi Liquid Knife & Immuno Therapy: UMIPIC | Zomwe zikuchitika Panopa mu Zachipatala & Sayansi Yamankhwala ISSN:2689-4246 Tsiku Losindikizidwa: Marichi 20, 2020 |
| 2022 | Acute Tumor Inflammation ndi CD4/8+ ndi CD11+ Yowonjezera Kupulumuka Kwanthawi yayitali M'magawo Otsogola a zotupa zonse zolimba ndi Ultra Minimum Incision Personalized Intratumoral Chemoimmunotehrapy | Japanese Journal of Gastroenterology ndi Hepatology |
| 2022 | Kutupa Kwambiri Ndi Kuwonetsa Kwapadera kwa CD11 & CD4 Kumapanga Abscopal Effect ndi Intramoral Injection Chemotherapy Drug with Hapten in Animal Model. | Journal of Immunological Sciences |
| 2022 | Nyengo Yatsopano Yopangira Opaleshoni Yoteteza Immuno Ikubwera: Njira Yatsopano Yopangira Chithandizo cha Khansa ndi Liquid Knife & Immuno Therapy | Academic Journal of Engineering Studies |
| 2022 | Acute Tumor Inflammation ndi CD4 / 8 + ndi CD11 + Kutalikitsa Mphamvu Yopulumuka Yopangidwa ndi Intratumral Injection Optimum Combination of Chemotherapy Drugs ndi Hydralazine monga Hapten mu Animal Model. | Japanese Journal of Gastroenterology ndi Hepatology |
| 2023 | Ganizirani Maselo Oteteza Chitetezo ndi Hapten Yowonjezera Intratumoral Chemotherapy yokhala ndi Penicillin Prolong Pancreatic Cancer Survival | Journal ya Cancer 2023; 14(8): 1282-1292 |
| 2023 | Kuwongolera bwino mu situ ya antigen ya nyukiliya ya oncogenic ndi chotupa chopangidwa ndi hapten chogwirizana ndi ma autoantibodies (iTAA) | Natural portfolio Scientific Reports voliyumu 13, Nambala yankhani: 9902 (2023) |
| 2023 | Kusintha kwa Immune Kumayambitsidwa ndi Intratumoral Hapten Plus Chemotherapy Mankhwala a EndometrialCancer | Journal of Basic and Clinical Pharmacy Julayi 31,2023. DOI: 10.37532/0976-0113.14(S1).17 |
| 2023 | Kukonzekera kwa Khansa Immunotherapy ndi Kuyambitsa Maselo Oteteza Chitetezo Kudzera mu Hapten-Enhanced Chemotherapy mu Primary Lung Cancer | Journal of Basic and Clinical Pharmacy August 11, 2023. DOI: 10.37532/0976-0113.14(S1).18 |
| 2023 | scRNA-Seq Analysis Kusintha kwa Immune Kusintha kwa Intratumoral Hapten Plus Chemotherapy Mankhwala Ochizira Khansa Yam'mawere Yamwamuna | JOURNAL OF CANCER SCIENCE AND CLINICAL THERAPEUTICS November 27, 2023. DOI:10.26502/jcsct.5079214 |
| 2024 | Zotsatira za sodium stibogluconate pakulembera ndi kudzutsa maselo a chitetezo chamthupi mu pleural fluid ya pancreatic cancer yokonzekera immunotherapy. | Frontiers in Immunology January 19, 2024. DOI:10.3389/fimmu.2023.1315468 |
| 2024 | Hapten-Mediated Chemical Immune Therapy with Drug Administration mu Cervical Cancer popanda Hysterectomy | Journal of Surgery June 13, 2024. DOI:10.29011/2575-9760.11063 |
| 2024 | Gwiritsani Ntchito Mbiri ya scRNA-Seq Kutanthawuza Immunologic Response Pambuyo pa Intra-tumor Hapen Enhanced Chemotherapy pa Nkhani ya Intracranial Anaplastic Hemangiopericytoma Liver Metastasis: Lipoti la Nkhani | Journal of Surgery June 10, 2024. DOI:10.29011/2575-9760.11063 |